New methods to control neuroblastoma growth

Cancer Biol Ther. 2014 May;15(5):481-2. doi: 10.4161/cbt.28465. Epub 2014 Mar 11.

Abstract

Downstream of growth factor receptors, signaling by the phosphoinositide 3 kinase (PI3K) pathway is known to play an important role in the growth and survival of many tumor types. The PI3K pathway simplistically comprises PI3K itself, followed by PDK-1, then AKT and finally glycogen synthase kinase 3 (GSK3). PI3K/AKT signaling promotes increased GSK3 phosphorylation, that is associated with reduced GSK3 activity. There are two isoforms of GSK3, GSK3α and GSK3β, which have a high degree of sequence homology. GSK3 plays a role not only in the regulation of glycogen synthase activity but in the expression of multiple other proteins that play a role in cancer biology, including cyclins and anti-apoptotic proteins.

Keywords: AR-A014418; GSK3; apoptosis; neuroblastoma.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Biomarkers, Tumor / antagonists & inhibitors*
  • Bone Marrow Neoplasms / pathology*
  • Cell Proliferation / drug effects*
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors*
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Neuroblastoma / pathology*
  • Thiazoles / pharmacology*
  • Urea / analogs & derivatives*
  • Urea / pharmacology

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Thiazoles
  • N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea
  • Urea
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
  • glycogen synthase kinase 3 alpha